Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.
Revenue (Most Recent Fiscal Year) | -- |
Net Income (Most Recent Fiscal Year) | $-11.44M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | -- |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.22 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -- |
Net Margin (Trailing 12 Months) | -- |
Return on Equity (Trailing 12 Months) | -110.27% |
Return on Assets (Trailing 12 Months) | -94.20% |
Current Ratio (Most Recent Fiscal Quarter) | 16.19 |
Quick Ratio (Most Recent Fiscal Quarter) | 16.19 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | -- |
Book Value per Share (Most Recent Fiscal Quarter) | $0.80 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.08 |
Earnings per Share (Most Recent Fiscal Year) | $-0.73 |
Diluted Earnings per Share (Trailing 12 Months) | $-0.65 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Common Shares Outstanding | 36.38M |
Free Float | 34.65M |
Market Capitalization | $97.49M |
Average Volume (Last 20 Days) | 1.71M |
Beta (Past 60 Months) | 1.15 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 4.74% |
Percentage Held By Institutions (Latest 13F Reports) | 16.30% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |